MPs launch inquiry into influence of drug industry

BMJ 2004; 329 doi: 10.1136/bmj.329.7466.587-a (Published 9 September 2004)
Cite this as: BMJ 2004;329:587.2

Access to the full text of this article requires a subscription or payment. Please log in or subscribe below.

  1. Ray Moynihan
  1. London

    The House of Commons Health Committee held its first public hearing this week as part of a wide ranging inquiry into the influence of the pharmaceutical industry over the health system.

    The committee is investigating drug companies' influence on medical research, the education of doctors, health information, and drug evaluation. It will specifically …

    Access to the full text of this article requires a subscription or payment

    Article access

    Article access for 1 day

    Purchase this article for £20 $30 €32*

    The PDF version can be downloaded as your personal record

    * Prices do not include VAT

    THIS WEEK'S POLL